Advertisement

ACB

Aurora Cannabis Inc.

Healthcare · USD

Set alert

Price alert · ACB

All alert types
4.06 USD -0.02 -0.49%
As of Oct 30, 2026 Extended hours 3.98 -1.97%
Bid
4.06 × 1
Ask
4.07 × 1
3.99 Day range 4.09
2.58 52-week range 5.57
YTD
-3.79%
1 year
-15.59%
Open
4.03
Prev close
4.08
Mkt cap
257.04M
Vol
807.14K
Avg vol
1.26M
EPS
-0.61
P/E
0.00
Div yield
0.00%
More statistics
Low
3.99
High
4.09
Forward P/E
-38.82
Beta
2.70
Short ratio
3.61
Inst. own
13.03%
Dividend
0.00
Ex-div date
Earnings
Feb 13, 2025
50-d avg
4.88
200-d avg
5.62
1y target
0.00

5D chart

Chart tools
Interval
ACB five-day price chart3.843.924.004.084.16Oct 26Oct 27Oct 28Oct 30

Key statistics

Market cap
234.33M
Enterprise value
233.55B
Trailing P/E
0.00
Forward P/E
-38.82
PEG ratio
0.00
Price / sales
0.79
Price / book
427.00
EPS (TTM)
-0.47
Beta
2.70
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-14.71%
Revenue (TTM)
296.99M
Revenue growth
28.50%
Free cash flow
-84.08M
Total cash
84.92M
Total debt
100.97M
Return on equity
-5.79%
Shares outstanding
54.88M
Short % of float
0.00%
50-day average
4.88
200-day average
5.62

Analyst view

Consensus: buy

Buy
Price target (mean) 0.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold4
  • Sell0
  • Strong sell0

Next earnings

Feb 13, 2025

Expected Feb 13, 2025. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
ACB Revenue — quarterly 67.55M
2023-Q1 20222023-Q2 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
ACB Net income — quarterly -4.03M
2023-Q1 20222023-Q2 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
ACB EPS — quarterly -0.07
2023-Q1 20222023-Q2 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026

Earnings

ACB recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 13, 2025Dec 1, 20240.04———
Nov 6, 2024Sep 1, 2024-0.220.04+0.26+118.18%
Aug 7, 2024Jun 1, 2024-0.35-0.11+0.24+68.57%
Aug 7, 2024Jun 1, 2024-0.35———
Jun 20, 2024Mar 1, 2024-0.180.11+0.29+161.11%
Jun 20, 2024Mar 1, 2024-0.18———

About Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada
Website
auroramj.com

News

Your note

Sign in to keep a note on ACB — it syncs with the Stock Master app.

Insider holders

ACB insider holders
InsiderRelationLatest transactionDateShares held
Beauchamp (Norma)Director of IssuerAcquisition or disposition in the public marketNov 14, 20222,595
Clark (Nathalie)Senior Officer of IssuerAcquisition or disposition in the public marketJun 6, 20222,700
Funk, RonaldDirector of IssuerAcquisition or disposition in the public marketJun 6, 202256,752
Ibbott William GlenSenior Officer of IssuerAcquisition or disposition in the public marketJun 6, 202243,048
Jerome (Andre)Senior Officer of IssuerExercise of rightsNov 22, 202235,052
Kohli (Chitwant S)Director of IssuerAcquisition or disposition in the public marketMay 30, 202260,000

Institution ownership

ACB institution ownership
Holder% heldSharesValueReported
Tidal Investments, LLC2.45%1,344,3215.74MSep 29, 2024
Renaissance Technologies, LLC1.20%658,2552.81MSep 29, 2024
Goldman Sachs Group Inc0.73%402,8141.72MSep 29, 2024
Morgan Stanley0.36%194,820831.88KSep 29, 2024
Susquehanna International Group, LLP0.29%159,051679.15KSep 29, 2024
Jane Street Group, LLC0.24%129,343552.29KSep 29, 2024

Fund ownership

ACB fund ownership
Holder% heldSharesValueReported
Amplify ETF Tr-Amplify Alternative Harvest ETF2.45%1,341,6435.73MSep 29, 2024
DFA Investment Dimensions-Canadian Small Company Series0.11%61,293261.72KJul 30, 2024
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF0.08%45,349193.64KSep 29, 2024
Fidelity NASDAQ Composite Index Fund0.06%32,486138.72KOct 30, 2024
DFA International Core Equity Portfolio0.03%14,40161.49KJul 30, 2024
SPDR Portfolio Developed World ex-US ETF0.01%7,23230.88KSep 29, 2024
Advertisement